TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis.
Saved in:
| Title: | TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. |
|---|---|
| Authors: | Medford AJ; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Oshry L; Boston Medical Center, Boston, MA, USA.; Boston University School of Medicine, Boston, MA, USA., Boyraz B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kiedrowski L; Guardant Health, Inc., Redwood City, CA, USA., Menshikova S; BostonGene Corporation, Boston, MA, USA., Butusova A; BostonGene Corporation, Boston, MA, USA., Dai CS; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Gogakos T; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Keenan JC; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Occhiogrosso RH; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Dana Farber Cancer Institute, Boston, MA, USA., Ryan P; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Lennerz JK; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Spring LM; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Jan 30; Vol. 15, pp. 17588359231152844. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359231152844 |
